ZA200707929B - Azole derivatives in the form of lipase and phospholipase inhibitors - Google Patents
Azole derivatives in the form of lipase and phospholipase inhibitorsInfo
- Publication number
- ZA200707929B ZA200707929B ZA200707929A ZA200707929A ZA200707929B ZA 200707929 B ZA200707929 B ZA 200707929B ZA 200707929 A ZA200707929 A ZA 200707929A ZA 200707929 A ZA200707929 A ZA 200707929A ZA 200707929 B ZA200707929 B ZA 200707929B
- Authority
- ZA
- South Africa
- Prior art keywords
- lipase
- azole derivatives
- phospholipase inhibitors
- phospholipase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005018389A DE102005018389A1 (de) | 2005-04-20 | 2005-04-20 | Azolderivate als Inhibitoren von Lipasen und Phospholipasen |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200707929B true ZA200707929B (en) | 2008-12-31 |
Family
ID=36694158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200707929A ZA200707929B (en) | 2005-04-20 | 2007-09-17 | Azole derivatives in the form of lipase and phospholipase inhibitors |
Country Status (20)
Country | Link |
---|---|
US (1) | US8921404B2 (ko) |
EP (1) | EP1874741A1 (ko) |
JP (1) | JP2008536884A (ko) |
KR (1) | KR20080004501A (ko) |
CN (1) | CN101160293A (ko) |
AR (1) | AR053228A1 (ko) |
AU (1) | AU2006237127A1 (ko) |
BR (1) | BRPI0608495A2 (ko) |
CA (1) | CA2606301A1 (ko) |
DE (1) | DE102005018389A1 (ko) |
IL (1) | IL186635A0 (ko) |
MA (1) | MA29393B1 (ko) |
MX (1) | MX2007012732A (ko) |
MY (1) | MY142441A (ko) |
NO (1) | NO20075938L (ko) |
NZ (1) | NZ562694A (ko) |
RU (1) | RU2414458C2 (ko) |
TW (1) | TW200722421A (ko) |
WO (1) | WO2006111321A1 (ko) |
ZA (1) | ZA200707929B (ko) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0715160A2 (pt) | 2006-08-08 | 2013-06-11 | Sanofi Aventis | imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso |
RU2009140760A (ru) | 2007-04-05 | 2011-05-10 | Санофи-Авентис (Fr) | 5-оксоизоксазолы в качестве ингибиторов липаз и фосфолипаз |
KR20090126293A (ko) | 2007-04-05 | 2009-12-08 | 사노피-아벤티스 | 리파제 및 포스포리파제 억제제로서의 이미다졸리딘 카복사미드 유도체 |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
US8957219B2 (en) | 2008-10-17 | 2015-02-17 | Shionogi & Co., Ltd. | Acetic acid amide derivative having inhibitory activity on endothelial lipase |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
GB2466121B (en) * | 2008-12-15 | 2010-12-08 | Amira Pharmaceuticals Inc | Antagonists of lysophosphatidic acid receptors |
EP2470552B1 (en) | 2009-08-26 | 2013-11-13 | Sanofi | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
CN102753545A (zh) | 2009-12-15 | 2012-10-24 | 盐野义制药株式会社 | 具有血管内皮脂酶抑制活性的噁二唑衍生物 |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
US20130197043A1 (en) | 2010-08-31 | 2013-08-01 | Snu R&Db Foundation | Use of the fetal reprogramming of a ppar agonist |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US9321787B2 (en) * | 2011-07-07 | 2016-04-26 | Sanofi | Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
CN108349997A (zh) * | 2015-08-27 | 2018-07-31 | 奥克兰联合服务有限公司 | 色氨酸双加氧酶(ido1和tdo)抑制剂及其在治疗中的用途 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030114420A1 (en) * | 2000-06-28 | 2003-06-19 | Salvati Mark E. | Fused cyclic modulators of nuclear hormone receptor function |
EP1355651A2 (en) * | 2001-02-02 | 2003-10-29 | Pfizer Limited | Treatment of diabetes mellitus using vardenafil |
WO2003005184A2 (en) | 2001-07-04 | 2003-01-16 | Akodi S.A. | Web windowed graphical user interface |
JP2003033007A (ja) | 2001-07-09 | 2003-01-31 | Sanyo Electric Co Ltd | チャージポンプ回路の制御方法 |
IL162270A0 (en) * | 2001-12-14 | 2005-11-20 | Novo Nordisk As | Compounds and uses thereof for decreasing activityof hormone-sensitive lipase |
DE60326646D1 (de) | 2002-12-18 | 2009-04-23 | Vertex Pharma | Benzisoxazolderivate, die sich als inhibitoren von proteinkinasen eigen |
US7595403B2 (en) * | 2003-04-01 | 2009-09-29 | Eli Lilly And Company | Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors |
EP1613608A1 (en) * | 2003-04-01 | 2006-01-11 | Eli Lilly And Company | Phospholipase inhibitors |
JP2007529468A (ja) * | 2004-03-16 | 2007-10-25 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ベンズイソオキサゾール |
TW200633990A (en) * | 2004-11-18 | 2006-10-01 | Takeda Pharmaceuticals Co | Amide compound |
-
2005
- 2005-04-20 DE DE102005018389A patent/DE102005018389A1/de not_active Withdrawn
-
2006
- 2006-04-13 WO PCT/EP2006/003411 patent/WO2006111321A1/de active Application Filing
- 2006-04-13 NZ NZ562694A patent/NZ562694A/en not_active IP Right Cessation
- 2006-04-13 KR KR1020077024150A patent/KR20080004501A/ko not_active Application Discontinuation
- 2006-04-13 MX MX2007012732A patent/MX2007012732A/es unknown
- 2006-04-13 BR BRPI0608495-8A patent/BRPI0608495A2/pt not_active IP Right Cessation
- 2006-04-13 RU RU2007142657/04A patent/RU2414458C2/ru not_active IP Right Cessation
- 2006-04-13 JP JP2008506977A patent/JP2008536884A/ja not_active Abandoned
- 2006-04-13 EP EP06761897A patent/EP1874741A1/de not_active Withdrawn
- 2006-04-13 CA CA002606301A patent/CA2606301A1/en not_active Abandoned
- 2006-04-13 CN CNA2006800127294A patent/CN101160293A/zh active Pending
- 2006-04-13 AU AU2006237127A patent/AU2006237127A1/en not_active Abandoned
- 2006-04-18 TW TW095113710A patent/TW200722421A/zh unknown
- 2006-04-18 AR ARP060101521A patent/AR053228A1/es not_active Application Discontinuation
- 2006-04-19 MY MYPI20061785A patent/MY142441A/en unknown
-
2007
- 2007-09-17 ZA ZA200707929A patent/ZA200707929B/xx unknown
- 2007-10-12 MA MA30299A patent/MA29393B1/fr unknown
- 2007-10-14 IL IL186635A patent/IL186635A0/en unknown
- 2007-10-17 US US11/873,846 patent/US8921404B2/en not_active Expired - Fee Related
- 2007-11-19 NO NO20075938A patent/NO20075938L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20080090867A1 (en) | 2008-04-17 |
MA29393B1 (fr) | 2008-04-01 |
IL186635A0 (en) | 2008-01-20 |
MX2007012732A (es) | 2008-03-14 |
JP2008536884A (ja) | 2008-09-11 |
US8921404B2 (en) | 2014-12-30 |
MY142441A (en) | 2010-11-30 |
AU2006237127A1 (en) | 2006-10-26 |
CN101160293A (zh) | 2008-04-09 |
CA2606301A1 (en) | 2006-10-26 |
EP1874741A1 (de) | 2008-01-09 |
WO2006111321A1 (de) | 2006-10-26 |
BRPI0608495A2 (pt) | 2010-01-05 |
KR20080004501A (ko) | 2008-01-09 |
NO20075938L (no) | 2007-11-19 |
TW200722421A (en) | 2007-06-16 |
DE102005018389A1 (de) | 2006-10-26 |
NZ562694A (en) | 2010-05-28 |
AR053228A1 (es) | 2007-04-25 |
RU2414458C2 (ru) | 2011-03-20 |
RU2007142657A (ru) | 2009-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL186635A0 (en) | Azole derivatives in the form of lipase and phospholipase inhibitors | |
ZA200802105B (en) | Diacyl indazol derivatives as lipase and phospholipase inhibitors | |
HUS2200052I1 (hu) | Imidazotriazinok és imidazopirimidinek mint kinázgátlók | |
IL250678A0 (en) | Compounds and methods for repressing pcsk9 gene expression | |
IL190714A0 (en) | Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases | |
ZA200802369B (en) | Triazolopyridine derivatives as inhibitors of lipases and phospholipases | |
IL182726A0 (en) | 5-heteroaryl thiazoles and their use as p13k inhibitors | |
ZA200704888B (en) | Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases | |
PL2253614T3 (pl) | Inhibitory IAP | |
PL1778718T3 (pl) | Inhibitory IAP | |
EP1742627A4 (en) | PDE4B HEMMER AND ITS USE | |
EP1931205A4 (en) | TRANSGLUTAMINASE INHIBITORS AND METHOD OF USE THEREOF | |
IL196860A0 (en) | Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors | |
ZA200906211B (en) | Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors | |
IL187728A0 (en) | Benzooxazole-2-on derivatives as lipase and phospholipase inhibitors | |
IL187730A0 (en) | Azolopyridine-2-on derivatives as lipase and phospholipase inhibitors | |
EP1877424A4 (en) | INHIBITORS OF PROTEIN KINASES AND USES THEREOF | |
IL187729A0 (en) | Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors | |
IL181819A0 (en) | Enzyme inhibitors and uses thereof | |
ZA200707359B (en) | Inhibitors of neurotrypsin and determination thereof | |
AU2006259113A8 (en) | Use of PDE1C and inhibitors thereof | |
HU0402439D0 (en) | Adaptation of laser technology in war industry | |
HK1142628A1 (en) | Compositions and methods for inhibiting expression of the pcsk9 gene | |
PL381202A1 (pl) | Pochodne izochinolinowe i sposoby ich stosowania |